Leadership winner, medium company ? Kevin Gorman of Neurocrine Biosciences

Neurocrine Biosciences has experienced a dramatic turnaround in recent years. The Carmel Valley-based biotech company has seen its stock price grow from $10 a share five years ago to about $115 a share, thanks in large part to the development of two drugs it recently introduced.

Ingrezza helps…